1. Home
  2. ELP vs HALO Comparison

ELP vs HALO Comparison

Compare ELP & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Companhia Paranaense de Energia (COPEL)

ELP

Companhia Paranaense de Energia (COPEL)

HOLD

Current Price

$10.56

Market Cap

7.6B

Sector

Utilities

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$63.22

Market Cap

7.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELP
HALO
Founded
1954
1998
Country
Brazil
United States
Employees
N/A
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
7.4B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
ELP
HALO
Price
$10.56
$63.22
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$73.33
AVG Volume (30 Days)
322.8K
2.5M
Earning Date
11-12-2025
11-03-2025
Dividend Yield
2.38%
N/A
EPS Growth
N/A
56.68
EPS
0.14
4.74
Revenue
$4,681,123,759.00
$1,242,852,000.00
Revenue This Year
N/A
$34.83
Revenue Next Year
$6.83
$24.84
P/E Ratio
$17.86
$13.14
Revenue Growth
12.38
31.19
52 Week Low
$5.72
$46.26
52 Week High
$11.23
$79.50

Technical Indicators

Market Signals
Indicator
ELP
HALO
Relative Strength Index (RSI) 54.37 38.75
Support Level $9.96 $61.23
Resistance Level $11.13 $63.26
Average True Range (ATR) 0.28 2.24
MACD -0.04 -0.60
Stochastic Oscillator 54.27 15.32

Price Performance

Historical Comparison
ELP
HALO

About ELP Companhia Paranaense de Energia (COPEL)

Cia Paranaense De Energia Copel is engaged in the areas of generation, transmission, commercialization and distribution of energy. It operates a comprehensive and effective electrical system with its own generating plants, transmission lines, substations, electrical lines and grids of the distribution system. The company's reportable segments include Power generation and transmission, Power distribution, GAS, Power sale, Services, and Holding. The majority of its revenue is generated from the Power generation and transmission segment under which it produces electricity from hydraulic, wind, and thermal projects and provides services of transmission and transformation of electric power and other related services.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: